DHG: Explanation for business results for 6 months of 2013 before & after review

DHG Pharmaceutical Joint Stock Company has explained for business results for the first six months of 2013 before & after review as follows:

	Before review	After review	Different	Rate (%)
Revenue	1,555,386,967,712	1,901,575,142,657	-346,188,174,945	-18.2
Deductions	-5,694,726,352	-351,882,901,297	346,188,174,945	-98,4

Reason:

-         The company attributed the changes to the classification of commercial discount into a separated item on its income statement instead of directly subtracting the revenues.

-         That did not affect to net revenue and business result:

	Before review	After review	Different	Rate (%)
Revenue	1,549,692,241,360	1,549,692,241,360	0	0
Profit before tax	311,275,072,452	311,275,072,452	0	0

HOSE

>   HSI: Explanation for business results for 6 months of 2013 before & after review (28/08/2013)

>   BMI: Reminded to submit the reviewed semi-annual financial statements (28/08/2013)

>   VNG: Explanation for reviewed semi- annual financial statements (28/08/2013)

>   PGT: Explanation for difference in profit QII.2013 (28/08/2013)

>   SCJ: Explanation for the change of over 10% in operating result in QI- 2013 (28/08/2013)

>   SD4: Result of Annual General Meeting of Shareholders 2013 (28/08/2013)

>   SD6: Result of Annual General Meeting of Shareholders 2013 (28/08/2013)

>   SD9: Result of Annual General Meeting of Shareholders 2013 (28/08/2013)

>   SDD: Result of Annual General Meeting of Shareholders 2013 (28/08/2013)

>   SDH: Result of Annual General Meeting of Shareholders 2013 (28/08/2013)